반응형
구분 보고서(영문)
제약/바이오/
임상시험
(11건)
Cell and Gene Therapy Companies Must Demonstrate Strong Value Proposition for Investment
RSV Prophylactic Market to Reach $6.2 Billion in 8MM by 2030
Schizophrenia Market Expected to Reach $17.0 Billion Across the 7MM by 2031
DREAM-HF Trial Sheds Positive Light on Revascor for Ischemic HF
Positive Interim Phase IIb Data Shows Promise of First Blood-Stage Malaria Vaccine
Biotech Bounces Back as Venture Funding Grows $3.8 Million from 2023 to 2024YTD
Christmas has come early for AbbVie as Tavapadon achieves positive topline results in Phase III TEMPO-2 Trial
Setback for UK Pharma as Government Sets Unexpectedly High VPAG Payback Rate in 2025
Emerging Market Quarterly Mergers, Acquisitions, and Financing – Q4 2024
Bio/Pharmaceutical Outsourcing Report, December 2024
From Davids to Goliaths: The GLP-1R Gold Rush
질환별
(7건)
Unmet Needs in the Chronic Hand Eczema Treatment Landscape
New Study Highlights the Increasing Incidence of Late-Onset Multiple Sclerosis in Italy
Bowel Cancer Cases are Rising Sharply in Younger Adult Population
Wrapping up the Year: Top HIV Drug Mechanisms “Sleighing” Through Late-Stage Pipeline
New Screening Recommendations for Critical Congenital Heart Defects
One-Third of Psoriatic Arthritis Cases Go Undiagnosed in Key Pharmaceutical Markets
Sodium Intake Linked to Atopic Dermatitis and Disease Severity
기타
(3건)
Waist-to-Hip Ratio a Better Predictor of Colorectal Cancer Risk than BMI
Knock-on Effects of Alcohol Consumption During the COVID-19 Pandemic in Brazil
Reprieve for WuXi as Biosecure Vote Likely Pushed to 2025

 

 

반응형
반응형
구분 보고서(영문)
제약/바이오/임상시험
(8건)
Europe’s TCR Immunotherapy Licensing Deals Surge 123% Higher than US in 2024
Exploring Drug Shortages in European Markets: the Causes, Analysis, and Response
Failure of AstraZeneca’s AZD4041 a Blow for Non-Opioid Treatments for Opioid Use Disorder
FDA Approves Medtronic InPen App, Launching Smart MDI System with Simplera CGM
Bio/Pharmaceutical Outsourcing Report, November 2024
Strategic Intelligence: Artificial Intelligence in Clinical Practice Physician Perspective – 2024
Navigating Medicine Pricing in Turkiye: the Pharmaceutical Euro Exchange Rate
Strategic Intelligence: Drug Development Trends in China
질환별
(2건)
The Race for Approval: Oral GLP-1R Therapies in Obesity
Parents Urged to Vaccinate Children in Wake of UK Pneumonia Epidemic
기타
(6건)
Trump’s Presidency Return: Boom or Bust for Biopharmaceutical Deal Activity?
UK Point-of-Care Production of Cell Therapies Could Arrive in 2025
Digital Marketing Trends: Hepatocellular Carcinoma
‘Like throwing a match into a powder keg’ – Trump agency nominations show pharma industry as divided as country
Study Shows Mortality Impact of Alcohol Consumption in Mexico
Net Zero Strategies in Healthcare
반응형
반응형
구분 보고서(영문)
제약/바이오/임상시험
(3건)
Positive Phase II Top-Line Data Highlights Omadacycline’s Potential in the NTM Market
Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share, and Outlook – 2024 Edition
Strategic Intelligence: AI in Drug Discovery 2024
컨퍼런스/심포지엄/학회/기타
(11건)
IDWeek 2024: Strategic Approaches and Challenges in Mpox Vaccination
AHA 2024: Plozasiran Demonstrates Promising Phase III Results in Adults with Familial Chylomicronemia Syndrome at High Risk of Acute Pancreatitis
AHA 2024: Lerodalciep Shows Promising Results in Open-Label Extension Trial in Patients With Heterozygous Familial Hypercholesterolemia
AHA 2024: Cardiovascular Effectiveness of GLP-1RA + Empagliflozin Combination Therapy in Adults with T2D
AHA 2024: Semaglutide Continues to Impress in Diabetic Kidney Disease
AHA 2024: CKD Patients Could Positively Benefit from an Aldosterone Synthase Inhibitor
AHA 2024: GLP-1R Agonist Treatment Associated with Better Clinical Outcomes in Patients with Heart Failure and CKD
AHA 2024: Phase III BROOKLYN Trial: Safety and Efficacy of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
AHA 2024: Zerlasiran Shows Promising Phase II Results in Patients with Elevated Lipoprotein(a) Levels
AHA 2024: Tirzepatide Improves Major Heart Failure Outcomes in Patients with HFpEF and Obesity in SUMMIT
AHA 2024: Muvalaplin Demonstrates Promising Phase II Results in Patients with Elevated Serum Lipoprotein(a)
질환별
(6건)
Parkinson's Disease Clinical Research in 7MM Focuses on Disease-Modifying Agents
Heart Failure: Seven-Market Drug Forecast and Market Analysis – Update
Type 1 Diabetes: Epidemiology Forecast to 2033
Neurofibromatosis: Competitive Landscape
Hepatitis B Virus Therapeutics: Competitive Landscape
Men’s Health Awareness Month Promotes Early Prostate Cancer Detection
반응형
반응형
구분 보고서(영문)
제약/바이오/임상시험
(8건)
Second Alzheimer’s Drug Rejected by NICE on the Same Day It Is Approved in the UK
EU Critical Medicines Act: Proposal Is One Step Closer to Ending Overreliance on Asian Manufacturers
Roche to Leverage Dyno Therapeutics Tech for Novel Gene Therapies in Neurological Disorders
Strategic Intelligence: Big Data in Pharma 2024
Strategic Intelligence: Digital Transformation and Emerging Technologies in the Healthcare Industry – 2024 Edition
Bio/Pharmaceutical Outsourcing Report, October 2024
Strategic Intelligence: Pharma M&A Deals Q3 2024 - Top Themes
Top 20 Biopharmas’ Market Cap Rises 2% in Q3 2024 Amid Flurry of Drug Approvals
컨퍼런스/
심포지엄/
학회/기타
(4건)
IDWeek 2024: Prevention and Treatment for HIV – Clinical Trials and Policy Challenges
IDWeek 2024: Kalihinol Analog Shows Promise as a Targeted Antimalarial Therapy
IDWeek 2024: The Efficacy of SCY-247 in Murine Models of Invasive Fungal Infections
Digital Marketing Trends in Non-small Cell Lung Cancer
질환별
(4건)
Glaucoma: Epidemiology Forecast to 2033
COPD: 68-Market Analysis and Sales Forecast
Recent Popularity of JAK Inhibitors in Atopic Dermatitis
Glomerulonephritis: Competitive Landscape

 

반응형

+ Recent posts